New analytical strategies can measure thousands of gut microbial proteins

The trillions of microorganisms living in our intestine influence our health, from digestion and metabolism to immunity. Yet scientists still struggle to understand how these microbes shape these important physiological functions because gut microbiomes are extraordinarily complex, redundant, and dynamic. New technologies are therefore essential for advancing microbiome research. Researchers at the University of Vienna have now reported effective strategies for simultaneously measuring thousands of microbial and host proteins. The findings have been published in Nature Communications.

Improving future microbiome research

Microorganisms are essential to the health of ecosystems across the planet, including the human body. Modern DNA sequencing has transformed microbiome research by revealing which microorganisms are present and which functions they could potentially perform. This is similar to identifying the musicians in an orchestra and the pieces they can play. However, DNA alone cannot tell us which piece is actually being performed.

Proteins provide this missing information. They reveal which microbial functions are active, how different microbiome members contribute, and importantly, how the host responds. In the orchestra analogy, proteins show not only which musicians are present, but also which piece they are playing and how the audience – the host – reacts.

In the new study, the researchers systematically compared five state-of-the-art mass spectrometry approaches using human fecal samples. Ultimately, they identified methodological strategies that provide high sensitivity, reproducibility, and functional insight. For this study researchers from the University of Vienna Bruker Daltonics Center of Excellence (CoE) for Metaproteomics and the Systems Biology of Pain Laboratory (Division of Pharmacology & Toxicology) at the University of Vienna worked together.

Metaproteomics allows us to see what microbial communities are actually doing, rather than simply which microbes are present. By identifying the most suitable analytical strategies, we hope to make future microbiome research more sensitive, reproducible, and accessible across medicine, environmental science, and biotechnology.”

Feng Xian, first author of the study

From technical developments to clinical insights

The researchers tested if the new analytical strategies also perform robustly in a biologically relevant setting. They measured microbial and host proteins throughout disease progression and recovery, revealing coordinated changes in microbial functions alongside the host repair response. The best-performing methods captured highly concordant host and microbial responses during the onset and recovery of intestinal inflammation, showing that technological improvements can translate into robust biological insights.

“Developing better technologies is essential if we want to answer the next generation of questions in microbiome research,” says David Gomez-Varela, Director of the CoE. “Only by listening to the music script played by microbes can we begin to understand why the audience – the host – responds in a particular way. This will transform our understanding of the microbiome’s role in human health. We are already applying these advances in international clinical collaborations to study the involvement of microbiomes in neurological, metabolic and autoimmune diseases.”

About Metaproteomics

The field of Metaproteomics is uniquely suited to simultaneously measure thousands of proteins – from microbes and their host. However, gut microbiomes are among the most complex biological samples known, containing proteins from hundreds of organisms across an enormous concentration range. Since its establishment in 2024, the CoE for Metaproteomics at the University of Vienna has been developing new technologies -from laboratory automation and advanced mass spectrometry to AI-based data analysis -to overcome these analytical challenges.

Summary 

• The gut microbiome cannot be fully understood by knowing which microbes are present; researchers must also determine what they are doing by analysing their proteins.
• Metaproteomics can reveal microbial activity by measuring thousands of proteins, but complex gut samples are technically difficult to analyze.
• The study shows that the choice of mass spectrometry acquisition strategy strongly affects sensitivity, reproducibility, and functional interpretation. The researchers provide practical guidance for selecting the most suitable method.
• The best-performing methods captured coordinated host and microbial responses during the onset and recovery of intestinal inflammation.
• These technologies provide a robust foundation for future clinical studies investigating how microbiomes contribute to human health and disease.